Free Trial

Indaptus Therapeutics (INDP) SEC Filings & 10K Form

Indaptus Therapeutics logo
$1.05 -0.01 (-0.94%)
(As of 10:01 AM ET)

Recent Indaptus Therapeutics SEC Filings

DateFilerForm TypeView
10/22/2024
7:05 AM
Indaptus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
4:21 PM
Indaptus Therapeutics (Filer)
Form D/A
09/22/2024
11:15 PM
Indaptus Therapeutics (Filer)
Form EFFECT
09/12/2024
3:45 PM
Indaptus Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
08/22/2024
9:06 AM
Indaptus Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
08/12/2024
7:00 AM
Indaptus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
7:01 AM
Indaptus Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
7:16 AM
Indaptus Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/08/2024
4:30 PM
Indaptus Therapeutics (Issuer)
Meckler Jeffrey A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
7:00 AM
Indaptus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
4:28 PM
Indaptus Therapeutics (Filer)
Form 424B5
08/06/2024
4:23 PM
Indaptus Therapeutics (Filer)
Form 424B5
06/07/2024
3:30 PM
Indaptus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2024
7:00 AM
Indaptus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
7:05 AM
Indaptus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
7:06 AM
Indaptus Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2024
8:00 AM
Indaptus Therapeutics (Filer)
Form DEF 14A
04/26/2024
8:05 AM
Indaptus Therapeutics (Filer)
Form DEFA14A
03/25/2024
7:31 AM
Indaptus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
4:00 PM
Indaptus Therapeutics (Filer)
Form 424B5
03/13/2024
7:00 AM
Indaptus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
7:02 AM
Indaptus Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/04/2024
10:01 AM
Indaptus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2024
3:15 PM
Indaptus Therapeutics (Issuer)
Newman Michael James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
3:15 PM
Indaptus Therapeutics (Issuer)
Meckler Jeffrey A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
3:15 PM
Indaptus Therapeutics (Issuer)
Sassi Nir (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
3:15 PM
Indaptus Therapeutics (Issuer)
Waltzman Roger J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
3:15 PM
Indaptus Therapeutics (Issuer)
Linscott Walt Addison (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
3:05 PM
Indaptus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:INDP) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners